Search results for: 'Security Screening Systems Xray'

This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due ...

In a highly competitive market with increasing regulatory pressures, Frost & Sullivan has analyzed the current state of the Internet of Medical Things (IoMT) security industry and presents the results of its research in this Frost Radar™, a benchmarking system to spark companies to action according to parameters of growth and innovation. The repo...

This research service analyzes the market for high content screening technologies within the United States. The market was divided into the high content screening instrumentation and high content screening reagents and assays segments. Each segment covers market trends, technology trends, competitive structure, market share analysis, revenue foreca...

25 Jul 2018  |  North America  |  Market Research

Global X-ray Mammography Imaging Systems Market, Forecast to 2022

Evaluating Growth Patterns and Opportunities Across X-ray Mammography Sets

Infographics

×

Over the last 20 years, hospitals and imaging centers in developed economies have adopted X-ray mammography equipment to screen and diagnose breast cancer. This has led to significant reduction in mortality and prompted emerging countries to invest in population-based, organized screening. Significant investments in mammography technology have pave...

This Frost Radar™ benchmarks the growth and innovation activity of clinical decision support system (CDSS) vendors in their effort to provide end users with evidence to take the next best action. The CDSS role is evolving from just being the source of clinical knowledge at the point of care or facilitating clinical decision-making and workflow. New...

21 Jun 2018  |  North America  |  Market Research

Endoscope Reprocessing Systems and Software Solutions Market Assessment, United States, Forecast to 2022

Despite Reaching Near Saturation, the Market will Grow at Healthy Rate Driven by High Procedural Volume Growth Coupled with Consistently High Replacements and Newer Installations

Infographics

×

Endoscope reprocessing systems and workflow solutions was a $526.6 million market in the United States in 2017. It is expected to grow at healthy CAGR of 8.6% to reach $796.4 million in 2022. The market is segmented into two broad segments which are then divided into several sub-segments as mentioned below: • Endoscope reprocessing solutions ...

This report provides a strategic analysis and forecast of the HTS market. The major segments included in the scope of this report are consumables, contract screeners, and biotechnology& pharmaceuticals. Each segment covers technology, products, deals, patents, industry trends, and a revenue forecast and analysis. General market challenges, driver...

30 Sep 2015  |  North America  |  Market Research

The North American Patient Handling Systems Market

Increased Adoption of Patient Lifts in US Acute Care Hospitals Drives Market Growth

Infographics

×

In this study of the North American patient handling systems market, patient lifts are broadly segmented as ceiling and floor lifts. End users are segmented as acute care hospitals, long-term care, and home care. The US market accounts for about 83% of the total market by revenue and is expected to grow faster than the Canadian market. Penetration ...

17 Jul 2017  |  North America  |  Market Research

US Oncology Diagnostics Market, Forecast to 2021

Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection

Infographics

×

Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consolida...